Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...

FDA Clears Home Brain-Stimulation Device to Help Treat Depression FRIDAY, Dec. 12, 2025 (HealthDay News) — An at-home device that sends a gentle electrical current to the brain to help treat ...

The FDA has approved Flow, a prescription home-use cranial electrotherapy stimulation device, for treating moderate to severe major depressive disorder (MDD) in adults aged 18 years and older.

A new piece of wearable technology that emits small electrical pulses into the user's brain to ease the symptoms of depression has been approved for use in Australia. The Therapeutic Goods ...

A home-based brain stimulation device appeared to boost cognition in patients with early Alzheimer's disease (AD), although the effect was small, a new study showed. Patients who received active ...

The U.S. Food and Drug Administration cleared Flow Neuroscience’s at-home electrical stimulation headset for adults with moderate-to-severe depression A trial of 174 people found the device led to ...